FBLN2 and cancer: Based on the KEGG network enrichment analysis, DE proteins between the FBLN2 deficient and control groups were relatively scattered, including cancer-associated pathways, PI3K-AKT axis, focal adhesion, etc. By comparison, over 10% of DE proteins between the NPR3 deficient and control groups were clustered in the metabolic pathway (Figure 7).